Susan Jones

Susan’s primary area of practice is competition law, with a focus on merger clearances, competition and regulatory advisory work and ACCC investigations. She has extensive experience with multi-jurisdictional matters and in pharmaceuticals and healthcare.

Prior to joining Talbot Sayer, Susan was a partner in the Competition and Regulation group of Gilbert + Tobin, where her practice included advising on ACCC investigations and achieving merger clearances for Elanco’s acquisition of Bayer’s animal health business, Mylan’s merger with Upjohn to form Viatris, Culligan’s acquisition of Waterlogic, PAG’s acquisition of Patties Foods and Vesco Foods, and Cisco’s acquisition of Splunk.

She was formerly head of the global antitrust practice at Novartis in Switzerland. There she led the merger clearance process for Novartis’s acquisition of eye care company Alcon and Novartis’s series of transformational deals with GSK and Lilly. Prior to Novartis, Susan was a senior associate at Allen & Overy in Brussels and a senior investigator at the Australian Competition and Consumer Commission (ACCC) in Brisbane.

Competition and Regulation Partner Susan Jones brings to our team extensive industry experience in pharmaceuticals and healthcare, having previously been the head of the global antitrust practice at Swiss healthcare company Novartis.  Before joining Talbot Sayer, Susan was co-chair of Gilbert + Tobin’s Health + Life Sciences Group where her practice included advising pharmaceutical and healthcare companies in relation to proposed acquisitions, collaborations, licensing and distribution deals, patent settlements, procurement agreements and supply agreements.  Susan co-authored Australian chapters for Lexology’s Digital Health guide; GCR’s Guide to Life Sciences; and authored the pharmaceuticals chapter for GCR’s Asia-Pacific Review.

Susan is a member of the Mergers Working Group of the International Bar Association’s Antitrust Section, and the Global Competition Review’s editorial board.

Susan was recognised in the sixth edition of Women in Antitrust 2021 by the Global Competition Review and profiled in the Global Competition Review’s Corporate Counsel 2019 quadrennial list of the top inhouse antitrust lawyers in the world.